A Review of Collagen Cross-Linking in Cornea and Sclera
Riboflavin/UVA cross-linking is a technique introduced in the past decades for the treatment of keratoconus, keratectasia, and infectious keratitis. Its efficacy and safety have been investigated with clinical and laboratory studies since its first clinical application by Wollensak for the treatment...
Main Authors: | , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398937/ |
id |
pubmed-4398937 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-43989372015-04-28 A Review of Collagen Cross-Linking in Cornea and Sclera Zhang, Xiao Tao, Xiang-chen Zhang, Jian Li, Zhi-wei Xu, Yan-yun Wang, Yu-meng Zhang, Chun-xiao Mu, Guo-ying Review Article Riboflavin/UVA cross-linking is a technique introduced in the past decades for the treatment of keratoconus, keratectasia, and infectious keratitis. Its efficacy and safety have been investigated with clinical and laboratory studies since its first clinical application by Wollensak for the treatment of keratoconus. Although its complications are encountered during clinical practice, such as infection inducing risk, minimal invasion merits a further investigation on its future application in clinical practice. Recently, collagen cross-linking in sclera shows a promising prospect. In present study, we summarized the representative studies describing the clinical and laboratory application of collagen cross-linking published in past decades and provided our opinion on the positive and negative results of cross-linking in the treatment of ophthalmic disorders. Hindawi Publishing Corporation 2015 2015-04-02 /pmc/articles/PMC4398937/ /pubmed/25922758 http://dx.doi.org/10.1155/2015/289467 Text en Copyright © 2015 Xiao Zhang et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Zhang, Xiao Tao, Xiang-chen Zhang, Jian Li, Zhi-wei Xu, Yan-yun Wang, Yu-meng Zhang, Chun-xiao Mu, Guo-ying |
spellingShingle |
Zhang, Xiao Tao, Xiang-chen Zhang, Jian Li, Zhi-wei Xu, Yan-yun Wang, Yu-meng Zhang, Chun-xiao Mu, Guo-ying A Review of Collagen Cross-Linking in Cornea and Sclera |
author_facet |
Zhang, Xiao Tao, Xiang-chen Zhang, Jian Li, Zhi-wei Xu, Yan-yun Wang, Yu-meng Zhang, Chun-xiao Mu, Guo-ying |
author_sort |
Zhang, Xiao |
title |
A Review of Collagen Cross-Linking in Cornea and Sclera |
title_short |
A Review of Collagen Cross-Linking in Cornea and Sclera |
title_full |
A Review of Collagen Cross-Linking in Cornea and Sclera |
title_fullStr |
A Review of Collagen Cross-Linking in Cornea and Sclera |
title_full_unstemmed |
A Review of Collagen Cross-Linking in Cornea and Sclera |
title_sort |
review of collagen cross-linking in cornea and sclera |
description |
Riboflavin/UVA cross-linking is a technique introduced in the past decades for the treatment of keratoconus, keratectasia, and infectious keratitis. Its efficacy and safety have been investigated with clinical and laboratory studies since its first clinical application by Wollensak for the treatment of keratoconus. Although its complications are encountered during clinical practice, such as infection inducing risk, minimal invasion merits a further investigation on its future application in clinical practice. Recently, collagen cross-linking in sclera shows a promising prospect. In present study, we summarized the representative studies describing the clinical and laboratory application of collagen cross-linking published in past decades and provided our opinion on the positive and negative results of cross-linking in the treatment of ophthalmic disorders. |
publisher |
Hindawi Publishing Corporation |
publishDate |
2015 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398937/ |
_version_ |
1613212237779959808 |